Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

A pill for HIV prevention: déjà vu all over again?

Myers JE, Sepkowitz KA.

Clin Infect Dis. 2013 Jun;56(11):1604-12. doi: 10.1093/cid/cit085. Epub 2013 Feb 13. Review.

PMID:
23408681
2.

Cost-effectiveness of pre-exposure prophylaxis (PrEP) in preventing HIV-1 infections in rural Zambia: a modeling study.

Nichols BE, Boucher CA, van Dijk JH, Thuma PE, Nouwen JL, Baltussen R, van de Wijgert J, Sloot PM, van de Vijver DA.

PLoS One. 2013;8(3):e59549. doi: 10.1371/journal.pone.0059549. Epub 2013 Mar 18.

3.

Preexposure prophylaxis for the prevention of HIV transmission to women.

Aaron E, Cohan D.

AIDS. 2013 Jan 2;27(1):F1-5. doi: 10.1097/QAD.0b013e32835917b4.

PMID:
22914582
4.

Cost-effectiveness of pre-exposure prophylaxis for HIV: a review.

Schackman BR, Eggman AA.

Curr Opin HIV AIDS. 2012 Nov;7(6):587-92. doi: 10.1097/COH.0b013e3283582c8b. Review.

PMID:
23076124
5.

Preexposure prophylaxis: An emerging clinical approach to preventing HIV in high-risk adults.

Blackwell CW.

Nurse Pract. 2014 Sep 18;39(9):50-3. doi: 10.1097/01.NPR.0000452976.92052.fa. Review.

PMID:
25140852
6.

The performative function of expectations in translating treatment to prevention: the case of HIV pre-exposure prophylaxis, or PrEP.

Rosengarten M, Michael M.

Soc Sci Med. 2009 Oct;69(7):1049-55. doi: 10.1016/j.socscimed.2009.07.039. Epub 2009 Aug 18.

PMID:
19695756
7.

The risk of HIV drug resistance following implementation of pre-exposure prophylaxis.

van de Vijver DA, Boucher CA.

Curr Opin Infect Dis. 2010 Dec;23(6):621-7. doi: 10.1097/QCO.0b013e32833ff1e6. Review.

PMID:
20847692
8.

The promise of pre-exposure prophylaxis with antiretroviral drugs to prevent HIV transmission: a review.

Hankins CA, Dybul MR.

Curr Opin HIV AIDS. 2013 Jan;8(1):50-8. doi: 10.1097/COH.0b013e32835b809d. Review.

PMID:
23201856
9.

[Pre-exposure prophylaxis for the prevention of sexual HIV transmission; new preventative strategy using tenofovir/emtricitabine].

Boot J, Rump BO, Boucher CA, Op de Coul EL, van Agtmael MA, van de Vijver DA, Burger DM, Fanoy EB.

Ned Tijdschr Geneeskd. 2013;157(27):A6063. Review. Dutch.

PMID:
23838402
10.

Antiretroviral pre-exposure prophylaxis (PrEP) for preventing HIV in high-risk individuals.

Okwundu CI, Okoromah CA.

Cochrane Database Syst Rev. 2009 Jan 21;(1):CD007189. doi: 10.1002/14651858.CD007189.pub2. Review. Update in: Cochrane Database Syst Rev. 2012;7:CD007189.

PMID:
19160329
11.

Challenges and opportunities for oral pre-exposure prophylaxis in the prevention of HIV infection: where are we in Europe?

Molina JM, Pintado C, Gatey C, Ponscarme D, Charbonneau P, Loze B, Rozenbaum W, Delaugerre C.

BMC Med. 2013 Aug 23;11:186. doi: 10.1186/1741-7015-11-186. Review.

12.

Helping our patients take HIV pre-exposure prophylaxis (PrEP): a systematic review of adherence interventions.

Marcus JL, Buisker T, Horvath T, Amico KR, Fuchs JD, Buchbinder SP, Grant RM, Liu AY.

HIV Med. 2014 Aug;15(7):385-95. doi: 10.1111/hiv.12132. Epub 2014 Feb 24. Review.

13.

The chronicles of HIV therapeutics: where to begin, when to start and how will it end--a tale of two decades and beyond?

Phillips EJ, Tseng A.

Can J Clin Pharmacol. 2002 Fall;9(3):120-2. No abstract available.

PMID:
12422248
14.

Antiretroviral prophylaxis for sexual and injection drug use acquisition of HIV.

Campbell JD, Herbst JH, Koppenhaver RT, Smith DK.

Am J Prev Med. 2013 Jan;44(1 Suppl 2):S63-9. doi: 10.1016/j.amepre.2012.09.045. Review.

PMID:
23253764
15.

Oral pre-exposure prophylaxis for HIV prevention.

García-Lerma JG, Paxton L, Kilmarx PH, Heneine W.

Trends Pharmacol Sci. 2010 Feb;31(2):74-81. doi: 10.1016/j.tips.2009.10.009. Epub 2009 Dec 4. Review.

PMID:
19963288
16.

PrEP implementation: moving from trials to policy and practice.

Cáceres CF, O'Reilly KR, Mayer KH, Baggaley R.

J Int AIDS Soc. 2015 Jul 20;18(4 Suppl 3):20222. doi: 10.7448/IAS.18.4.20222. eCollection 2015.

17.

Preparing for PrEP.

Lacor P.

Eur J Contracept Reprod Health Care. 2012 Dec;17(6):482-6. doi: 10.3109/13625187.2012.723225. Epub 2012 Oct 31.

PMID:
23113873
18.

The potential impact of pre-exposure prophylaxis for HIV prevention among men who have sex with men and transwomen in Lima, Peru: a mathematical modelling study.

Gomez GB, Borquez A, Caceres CF, Segura ER, Grant RM, Garnett GP, Hallett TB.

PLoS Med. 2012;9(10):e1001323. doi: 10.1371/journal.pmed.1001323. Epub 2012 Oct 9.

19.

HIV preexposure prophylaxis: new data and potential use.

Celum CL.

Top Antivir Med. 2011 Dec;19(5):181-5.

20.

The history of antiretrovirals: key discoveries over the past 25 years.

De Clercq E.

Rev Med Virol. 2009 Sep;19(5):287-99. doi: 10.1002/rmv.624.

PMID:
19714702

Supplemental Content

Support Center